Files in this item



application/pdfjama_sherkow_2021_vp_210101_1631920919.41426.pdf (50kB)
(no description provided)PDF


Title:Governing Human Germline Editing Through Patent Law
Author(s):Sherkow, Jacob S.; Adashi, Eli Y.; Cohen, I. Glenn
Subject(s):hhge, genome editing, germline, crispr, patent
Abstract:In the wake of the heritable human genome editing (HHGE) experiments carried out by He Jiankui in China, widely condemned as unethical and scientifically ill grounded, attention has shifted to questions concerning hard law and regulation. The World Health Organization (WHO) recently released a report along with several auxiliary documents exploring international governance tools for human genome engineering. However, as long as such governance occurs only at the national legal level, the possibility of medical tourism to circumvent domestic prohibitions remains a risk. In this Viewpoint, we articulate the case for patent licensing as international governance instrument, as well as discussing patent law's limits.
Issue Date:2021-09-28
Citation Info:Jacob S. Sherkow, Eli Y. Adashi, & I. Glenn Cohen, Governing Human Germline Editing Through Patent Law, 326 JAMA 1149 (2021)
Date Available in IDEALS:2021-10-05

This item appears in the following Collection(s)

  • Illinois Research and Scholarship
    This is the default collection for all research and scholarship developed by faculty, staff, or students at the University of Illinois at Urbana-Champaign

Item Statistics